filmov
tv
JAK Therapies: Mechanism of Action, Pharmacotherapeutic Profiles, and Positioning
Показать описание
© 2021 Imedex, an HMP Company
HMP Education
HMP CME
Imedex
NACCME
IBD
inflammatory bowel disease
Рекомендации по теме
0:15:28
JAK Therapies: Mechanism of Action, Pharmacotherapeutic Profiles, and Positioning
0:03:15
Mechanism of Action of JAK Inhibitors
0:03:07
JAK (Janus Kinase Pathway) Inhibitor Tofacitinib - pharmacology, mechanism of action, side effects
0:15:32
The role of JAK inhibitors in your clinical practice
0:05:45
Tofacitinib | JAK (Janus Kinase Pathway) Inhibitor Tofacitinib - pharmacology, mechanism of action.
0:16:48
New Therapies that Target the JAK-STAT Pathway and other Small Molecules
0:06:17
JAK Inhibitors and Inflammatory Bowel Disease
0:43:42
JAK-Inhibition in Immune-Mediated Diseases (IMiDs)
0:01:25
IBD Medications: JAK Inhibitors
0:03:44
The JAK/STAT pathway
0:36:51
The Expanding Role of JAK Inhibitors Across IMIDs
0:00:16
#SHORTS MECHANISM OF ACTION OF JAK INHIBITORS
0:10:50
Decoding the Mechanism of Action of JAK (Janus Kinase) Inhibitors in Revolutionary Therapeutics
0:45:53
Strategies for Improving IMID Outcomes: The Potential of JAK Inhibitors
0:09:19
JAK-STAT Signaling Pathway
0:16:57
JAK inhibitors: Pharmacology & dermatological applications
0:10:50
Decoding the Mechanism of Action of JAK (Janus Kinase) Inhibitors in Revolutionary Therapeutics
0:22:00
Novel JAK Inhibitors Under Investigation for IBD
0:22:51
A user's guide to JAK inhibition for IBD
0:03:03
MOA of Nonselective vs. Selective JAK inhibitors
0:02:29
What Are the Long-Term Effects of JAK Inhibitors?
0:12:49
JAK inhibitors in Dermatology
0:06:10
JAK Inhibitors - New FDA Approved Treatment!
0:47:15
JAK Inhibitors in Action: Effectiveness in Atopic Dermatitis